146 related articles for article (PubMed ID: 38288514)
1. Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy.
Chen ZL; Jia KP; Zheng Y; Zhang N; Wang X; Tse G; Zhang ZW; Hu HL; Liu T
Ann Noninvasive Electrocardiol; 2024 Jan; 29(1):e13107. PubMed ID: 38288514
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy.
Chen Z; Lu K; Zhou L; Liu D; Li X; Han X; Tao H; Tse G; Zhang H; Liu T
J Electrocardiol; 2020; 60():195-199. PubMed ID: 32413696
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial.
Rüger AM; Schneeweiss A; Seiler S; Tesch H; van Mackelenbergh M; Marmé F; Lübbe K; Sinn B; Karn T; Stickeler E; Müller V; Schem C; Denkert C; Fasching PA; Nekljudova V; Garfias-Macedo T; Hasenfuß G; Haverkamp W; Loibl S; von Haehling S
J Am Heart Assoc; 2020 Dec; 9(23):e018143. PubMed ID: 33191846
[TBL] [Abstract][Full Text] [Related]
4. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Cohen V; Gosavi S; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Am J Cardiol; 2011 May; 107(9):1375-80. PubMed ID: 21371685
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy.
Liang X; Wang Y; Yin X; Gong X; Pan S; Chen Z; Geng X
Cardiol Res Pract; 2020; 2020():6678503. PubMed ID: 33376602
[TBL] [Abstract][Full Text] [Related]
6. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
[TBL] [Abstract][Full Text] [Related]
7. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
[TBL] [Abstract][Full Text] [Related]
8. Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab.
Andersson AE; Linderholm B; Giglio D
Acta Oncol; 2021 Apr; 60(4):475-481. PubMed ID: 33191817
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
Yu AF; Manrique C; Pun S; Liu JE; Mara E; Fleisher M; Patil S; Jones LW; Steingart RM; Hudis CA; Dang CT
Oncologist; 2016 Apr; 21(4):418-24. PubMed ID: 26984450
[TBL] [Abstract][Full Text] [Related]
10. The relationship between galectin-3 levels and fragmented QRS (fQRS) in patients with heart failure with reduced left ventricular ejection fraction.
Barman HA; Durmaz E; Atici A; Kahyaoglu S; Asoglu R; Sahin I; Ikitimur B
Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12671. PubMed ID: 31155816
[TBL] [Abstract][Full Text] [Related]
11. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels.
Kılıçkesmez KO; Bulut G; Başkurt M; Coşkun U; Yıldız A; Küçükoğlu S
Turk Kardiyol Dern Ars; 2011 Apr; 39(3):183-90. PubMed ID: 21532293
[TBL] [Abstract][Full Text] [Related]
12. Assessing the cardiotoxicity of Epirubicin-based chemotherapy in patients with breast cancer using high-sensitivity cardiac troponin T, N-terminal pro b-type natriuretic peptide and soluble suppression of tumorigenicity-2.
Isemede DA; Sharma A; Bailey J
Ann Clin Biochem; 2022 Nov; 59(6):410-419. PubMed ID: 36154484
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning.
Turan C; Dogan E; Yurtseven A; Saz EU
Cardiol Young; 2020 Aug; 30(8):1103-1108. PubMed ID: 32571446
[TBL] [Abstract][Full Text] [Related]
14. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Mean Heart Dose and Cardiac Biomarkers with Electrocardiographic Changes in Patients Receiving Thoracic Radiation Therapy.
Tao Y; Lu J; Deng W; Ma R; Tang S; Wei Y; Yuan S
Radiat Res; 2023 Apr; 199(4):336-345. PubMed ID: 36753532
[TBL] [Abstract][Full Text] [Related]
16. Preoperative cardiac screening using NT-proBNP in obese patients 50 years and older undergoing bariatric surgery: a study of 310 consecutive patients.
van Veldhuisen SL; van Woerden G; Hemels MEW; America YGCJ; de Boer RA; Rienstra M; van Veldhuisen DJ; Hazebroek EJ
Surg Obes Relat Dis; 2021 Jan; 17(1):64-71. PubMed ID: 33036941
[TBL] [Abstract][Full Text] [Related]
17. Assessment of global longitudinal strain and plasma natriuretic peptide in patients with asymptomatic left ventricular dysfunction.
Ulziisaikhan G; Khurelbaatar MU; Khorloo C; Sodovsuren N; Khasag A; Unurjargal T
Kardiologiia; 2021 Oct; 61(10):53-60. PubMed ID: 34763639
[TBL] [Abstract][Full Text] [Related]
18. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.
Romano S; Fratini S; Ricevuto E; Procaccini V; Stifano G; Mancini M; Di Mauro M; Ficorella C; Penco M
Br J Cancer; 2011 Nov; 105(11):1663-8. PubMed ID: 22068815
[TBL] [Abstract][Full Text] [Related]
19. Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study.
Dhir V; Yan AT; Nisenbaum R; Sloninko J; Connelly KA; Barfett J; Haq R; Kirpalani A; Chan KKW; Petrella TM; Brezden-Masley C
Int J Cardiovasc Imaging; 2019 Nov; 35(11):2085-2093. PubMed ID: 31197526
[TBL] [Abstract][Full Text] [Related]
20. Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.
De Iuliis F; Salerno G; Taglieri L; De Biase L; Lanza R; Cardelli P; Scarpa S
Tumour Biol; 2016 Mar; 37(3):3379-87. PubMed ID: 26449821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
